Science 37 optimizes recruitment and enrollment, improves patient retention, and expands access through partnerships with clients, CROs, industry lobby groups, and patient advocacy groups.
SCIENCE 37
Partnerships
Science 37 optimizes recruitment and enrollment, improves patient retention, and expands access through partnerships with clients, CROs, industry lobby groups, and patient advocacy groups.
It’s only by working together that we can accelerate drug development now and in the future.
Science 37 supports industry-leading pharmaceutical companies and emerging biotech, clinical research organizations (CROs), and medical device companies. The Science 37 Metasite enables expansive clinical trial access for patients—improving trial diversity, enrollment, and retention while mitigating risk.
